Advanced search
Publication Cover
OncoTargets and Therapy Volume 10, 2017 - Issue
Submit an article Journal homepage
43
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Clinical outcomes of epidermal growth factor receptor tyrosine kinase inhibitors in recurrent adenosquamous carcinoma of the lung after resection

Liwen Fan1 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
,
Haitang Yang1 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China;2 Division of General Thoracic Surgery, Inselspital University Hospital Bern, Bern, Switzerland
,
Feng Yao1 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
,
Yang Zhao1 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
,
Haiyong Gu1 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
,
Ke Han1 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
&
Heng Zhao1 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 239-245 | Published online: 06 Jan 2017

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Chao Zhang, Haitang Yang, Baoping Lang, Xiangdong Yu, Peng Xiao, Dian Zhang, Liwen Fan & Xiao Zhang. (2018) Surgical significance and efficacy of epidermal growth factor receptor tyrosine kinase inhibitors in patients with primary lung adenosquamous carcinoma. Cancer Management and Research 10, pages 2401-2407.
Read now
Jing Wang, Yanling Wang, Mengting Tong, Hongming Pan & Da Li. (2018) Research progress of the clinicopathologic features of lung adenosquamous carcinoma. OncoTargets and Therapy 11, pages 7011-7017.
Read now
Chenghui Li & Hongyang Lu. (2018) Adenosquamous carcinoma of the lung. OncoTargets and Therapy 11, pages 4829-4835.
Read now

Articles from other publishers (12)

Chunsen Wang, Xiang Yuan & Jianxin Xue. (2023) Targeted therapy for rare lung cancers: Status, challenges, and prospects. Molecular Therapy 31:7, pages 1960-1978.
Crossref
Edward S. Kim, Jonathan K. Kish, Agnieszka Cseh, Barbara Moehring, Wenbo Tang, Elizabeth Terlizzi & Janakiraman Subramanian. (2021) Second-line Afatinib or Chemotherapy Following Immunochemotherapy for the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: Real-world Effectiveness and Safety From a Multisite Retrospective Chart Review in the USA. Clinical Lung Cancer 22:4, pages 292-300.e1.
Crossref
Yong Cheng, Yanxiang Zhang, Yuwei Yuan, Jiao Wang, Ke Liu, Bin Yu, Li Xie, Chao Ou-Yang, Lin Wu & Xiaoqun Ye. (2021) The Comprehensive Analyses of Genomic Variations and Assessment of TMB and PD-L1 Expression in Chinese Lung Adenosquamous Carcinoma. Frontiers in Genetics 11.
Crossref
Wen Li, Yu Liu, Zi Jin Li, Yi Shi, Jing Deng, Jie Bai, Liang Ma, Xiao Xi Zeng, Shan Shan Feng, Jia Li Ren, Fei Jun Luo, Duo Yan Rong, Xiao Qi Chen, Hua Qun Yin, Zhu Chen & Fu Da. (2021) Unravelling the Role of LncRNA WT1-AS/miR-206/NAMPT Axis as Prognostic Biomarkers in Lung Adenocarcinoma. Biomolecules 11:2, pages 203.
Crossref
G. Lin, C. Li, P.S. Li, W.Z. Fang, H.P. Xu, Y.H. Gong, Z.F. Zhu, Y. Hu, W.H. Liang, Q. Chu, W.Z. Zhong, L. Wu, H.J. Wang, Z.J. Wang, Z.M. Li, J. Lin, Y.F. Guan, X.F. Xia, X. Yi, Q. Miao, B. Wu, K. Jiang, X.B. Zheng, W.F. Zhu, X.L. Zheng, P.S. Huang, W.J. Xiao, D. Hu, L.F. Zhang, X.R. Fan, T.S.K. Mok & C. Huang. (2020) Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma. Annals of Oncology 31:4, pages 517-524.
Crossref
Hsiang-Ling Ho, Hua-Lin Kao, Yi-Chen Yeh & Teh-Ying Chou. (2019) The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies. Diagnostic Pathology 14:1.
Crossref
Elyana Matayeva, Theresa Henson & Artur Alaverdian. (2019) A 38-Year-Old Man With An Ataxic Gait, Night Sweats, and Weight Loss. Chest 156:6, pages e133-e136.
Crossref
Minjuan Hu, Bo Zhang, Jianlin Xu, Shuyuan Wang, Yiming Zhao, Lele Zhang & Baohui Han. (2019) Clinical Outcomes of Different Generations of EGFR Tyrosine Kinase Inhibitors in Advanced Lung Adenosquamous Carcinoma. Molecular Diagnosis & Therapy 23:6, pages 773-779.
Crossref
Fumihiro Yamaguchi, Eisuke Kato, Aya Wakabayashi & Yusuke Shikama. (2019) Effect of osimertinib treatment on lung adenocarcinoma with squamous cell transformation harboring the T790M mutation: A case report and literature review. Molecular and Clinical Oncology.
Crossref
Alain C. Borczuk. (2018) Uncommon Types of Lung Carcinoma With Mixed Histology: Sarcomatoid Carcinoma, Adenosquamous Carcinoma, and Mucoepidermoid Carcinoma. Archives of Pathology & Laboratory Medicine 142:8, pages 914-921.
Crossref
Yuan Zhang, Yang-Chun Feng, Hong-Ge Zhu, Ting-Chuan Xiong, Yan-Shen Hou, Jia Song, Wei Jiang & Chang-Jun Zhu. (2018) The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs. Medicine 97:30, pages e11648.
Crossref
Elaine Tan, Mayur D. Mody & Nabil F. Saba. (2018) Systemic therapy in non-conventional cancers of the larynx. Oral Oncology 82, pages 61-68.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.